Vaginal Compared to Intramuscular Progesterone for Frozen Embryo Transfer

Completed · Phase 4

Conditions studied: Infertility

In brief

To determine whether the of vaginal progesterone replacement for frozen embryo transfer results in equivalent live birth rates to intramuscular injection progesterone replacement.

Key facts

Study ID

NCT02254577

Run by

Shady Grove Fertility Reproductive Science Center

People needed

1139

Starts

2014-10-01

Expected to finish

2018-04-27

Last updated by the study team

2018-08-02

Who can join

Age: 18 and older, up to 48. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Signed informed consent
• Female age between 18 and 48 years
• Having available blastocyst(s) frozen by vitrification method at our center (Shady Grove Fertility).
• Standard eligibility criteria to undergo frozen blastocyst transfer at Shady Grove Fertility.

You may not qualify if…

• Requires fresh embryos or surrogate carrier
• Embryos from frozen oocytes and embryos frozen more than once
• Any embryo cryopreserved by slow freeze method and/or prior to blastocyst stage
• Presence of any clinically relevant systemic disease contraindicated for ART
• History of more than 3 failed cycles in previous ART attempts and/or more than 3 recurrent pregnancy losses after ET
• Surgical or medical condition or requirement for medication, which may interfere with absorption, distribution, metabolism, or excretion of the drugs to be used
• Subjects with a body mass index (BMI) of <18 or >38 kg/m2 at screening
• Current or recent substance abuse, including alcohol and tobacco. (Note: Subjects who stopped tobacco usage at least 3 months prior to screening visit will be allowed)
• Currently breast feeding, pregnant, or having (a) contraindication(s) to pregnancy
• Refusal or inability to comply with the requirements of the protocol for any reason, including scheduled clinic visits and laboratory tests
• Trophectoderm or blastomere biopsy of the blastocyst(s) to be transferred.
• Documented intolerance or allergy to any of the medications used, including the study medication
• Participation in any experimental drug study within 60 days prior to screening
• If a subject undergoes more than two frozen blastocyst transfers meeting study criteria, she will only be eligible to enroll in the study for two of these.

Where it is running

• Shady Grove Fertility Center — Washington D.C., District of Columbia, United States
• Shady Grove Fertility Center — Washington D.C., District of Columbia, United States
• Shady Grove Fertility Center — Annapolis, Maryland, United States
• Shady Grove Fertility Center — Baltimore, Maryland, United States
• Shady Grove Fertility Center — Bel Air, Maryland, United States
• Shady Grove Fertility Center — Columbia, Maryland, United States
• Shady Grove Fertility Center — Frederick, Maryland, United States
• Shady Grove Fertility Center — Rockville, Maryland, United States
• Shady Grove Fertility Center — Towson, Maryland, United States
• Shady Grove Fertility — Camp Hill, Pennsylvania, United States
• Shady Grove Fertility Center — Chesterbrook, Pennsylvania, United States
• Shady Grove Fertility Center — Annandale, Virginia, United States
• Shady Grove Fertility Center — Leesburg, Virginia, United States
• Shady Grove Fertility Center — Woodbridge, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.